Garry E. Menzel

Insider Reports History

Location
San Diego, CA
Signature
/s/ Brent Hatzis-Schoch, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Garry E. Menzel:

Company Role Class Num Shares Value Price $ Report Date Ownership
Adaptimmune Therapeutics PLC Director American Depositary Shares representing Ordinary Shares 75,056 $50,513 $0.6730 10 Jul 2023 Direct
Adaptimmune Therapeutics PLC Director Option to purchase Ordinary Shares 1,121,604 01 Jul 2024 Direct
Black Diamond Therapeutics, Inc. Director Stock Option (Right to Buy) 30,550 12 Jun 2025 Direct
Stoke Therapeutics, Inc. Director Director Stock Option (Right to Buy) 29,747 03 Jun 2025 Direct
TCR2 THERAPEUTICS INC. President and CEO, Director Common Stock 0 $1.72 01 Jun 2023 Direct
TCR2 THERAPEUTICS INC. President and CEO, Director Common Stock 0 $1.72 01 Jun 2023 Indirect
TCR2 THERAPEUTICS INC. President and CEO, Director Restricted Stock Unit 0 01 Jun 2023 Direct
TCR2 THERAPEUTICS INC. President and CEO, Director Stock Option (Right to Buy) 0 $0.7400 01 Jun 2023 Direct

Insider Reports Filed by Garry E. Menzel

Symbol Company Period Transactions Value $ Form Type Role Filing Time
BDTX Black Diamond Therapeutics, Inc. 12 Jun 2025 1 $0 4 Director 12 Jun 2025, 18:26
STOK Stoke Therapeutics, Inc. 03 Jun 2025 1 $0 4 Director 04 Jun 2025, 20:35
ADAP Adaptimmune Therapeutics PLC 01 Jul 2024 1 $0 4 Director 01 Jul 2024, 17:03
BDTX Black Diamond Therapeutics, Inc. 06 Jun 2024 1 $0 4 Director 06 Jun 2024, 17:54
STOK Stoke Therapeutics, Inc. 05 Jun 2024 1 $0 4 Director 07 Jun 2024, 16:21
ADAP Adaptimmune Therapeutics PLC 10 Jul 2023 1 -$43,447 4 Director 10 Jul 2023, 17:01
ADAP Adaptimmune Therapeutics PLC 05 Jul 2023 7 $0 4 Director 05 Jul 2023, 17:00
ADAP Adaptimmune Therapeutics PLC 03 Jul 2023 1 $0 4 Director 03 Jul 2023, 17:03
STOK Stoke Therapeutics, Inc. 13 Jun 2023 1 $0 4 Director 15 Jun 2023, 18:25
ADAP Adaptimmune Therapeutics PLC 01 Jun 2023 3 $0 4 Director 01 Jun 2023, 16:59
ADAP Adaptimmune Therapeutics PLC 01 Jun 2023 0 $0 3 Director 01 Jun 2023, 16:50
TCRR TCR2 THERAPEUTICS INC. 01 Jun 2023 11 $0 4 President and CEO, Director 01 Jun 2023, 16:22
BDTX Black Diamond Therapeutics, Inc. 16 May 2023 1 $0 4 Director 17 May 2023, 21:08
TCRR TCR2 THERAPEUTICS INC. 15 Dec 2022 2 $0 4 President and CEO, Director 19 Dec 2022, 16:32
TCRR TCR2 THERAPEUTICS INC. 09 Dec 2022 3 -$35,034 4 President and CEO, Director 13 Dec 2022, 19:19
TCRR TCR2 THERAPEUTICS INC. 07 Dec 2022 2 -$23,360 4 President and CEO, Director 09 Dec 2022, 15:44
TCRR TCR2 THERAPEUTICS INC. 05 Dec 2022 2 -$31,784 4 President and CEO, Director 07 Dec 2022, 18:56
TCRR TCR2 THERAPEUTICS INC. 01 Dec 2022 5 -$11,687 4 President & CEO, Director 05 Dec 2022, 18:49
TCRR TCR2 THERAPEUTICS INC. 17 Nov 2022 12 $0 4 President and CEO, Director 18 Nov 2022, 15:56
TCRR TCR2 THERAPEUTICS INC. 05 Jul 2022 6 $0 4 President & CEO, Director 26 Aug 2022, 16:30
BDTX Black Diamond Therapeutics, Inc. 10 Jun 2022 1 $0 4 Director 13 Jun 2022, 19:04
STOK Stoke Therapeutics, Inc. 07 Jun 2022 1 $0 4 Director 08 Jun 2022, 17:00
TCRR TCR2 THERAPEUTICS INC. 28 Feb 2022 1 +$3,278 4 President & CEO, Director 18 Mar 2022, 16:24
TCRR TCR2 THERAPEUTICS INC. 31 Aug 2021 5 +$265,018 4 President & CEO, Director 10 Dec 2021, 15:32
BDTX Black Diamond Therapeutics, Inc. 18 Jun 2021 1 $0 4 Director 22 Jun 2021, 18:15
STOK Stoke Therapeutics, Inc. 08 Jun 2021 1 $0 4 Director 25 Jun 2021, 17:01